US Patent Issued to Claris Biotherapeutics on Nov. 3 for "Compositions of growth factor for the treatment of eye disease" (New Jersey Inventors)

ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,779,015, issued on Nov. 3, was assigned to Claris Biotherapeutics Inc. (Jersey City, N.J.).

"Compositions of growth factor for the treatment of eye disease" was invented by Piotr Bryla (Jersey City, N.J.) and A. Clarke Atwell (Jersey City, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to pharmaceutical compositions comprising a growth factor and methods of treating or preventing of eye diseases using the growth factor and compositions thereof."

The patent was filed on May 13, 2022, under Application No. 17/743,488.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/ne...